Ex Parte SpertusDownload PDFPatent Trial and Appeal BoardSep 23, 201310165855 (P.T.A.B. Sep. 23, 2013) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE ________________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ________________ Ex parte JOHN SPERTUS ________________ Appeal 2011-011083 Application 10/165,855 Technology Center 3600 ________________ Before MURRIEL E. CRAWFORD, MEREDITH C. PETRAVICK, and JAMES A. TARTAL, Administrative Patent Judges. TARTAL, Administrative Patent Judge. DECISION ON APPEAL Appeal 2011-011083 Application 10/165,855 2 STATEMENT OF THE CASE1 Appellant seeks our review under 35 U.S.C. § 134 of the Examiner’s decision rejecting claims 63-82.2 We have jurisdiction over the appeal pursuant to 35 U.S.C. § 6(b). We REVERSE and enter a NEW GROUND OF REJECTION under 37 C.F.R. § 41.50(b). Appellant’s claimed invention relates to the fields of clinical treatment plan assessment and selection, computer software programs, and cardiac patient care. Spec. 2, ll. 3-11. Claim 63, reproduced below, is illustrative of the subject matter on appeal: 63. A program stored in computer readable memory, that when executed by a computer system, is configured to: access, using the computer system, a database to retrieve information regarding a first individual patient; identify, using the computer system, a disease state of the first individual patient using information accessed from the database; assess, using the computer system, health status parameters of the first individual patient; 1 Our decision will make reference to Appellant’s Appeal Brief (“App. Br.,” filed Dec. 21, 2010) and Reply Brief (“Reply Br.,” filed Jun. 15, 2011), and the Examiner’s Answer (“Ans.,” mailed Apr. 15, 2011). 2 In summarizing the status of claims, Appellant states: “Claims 15-21, 24- 26, and 62-89 are now pending. Claims 15-21, 24-26 are withdrawn from consideration. Claims 1-14, 22, 23, 27-62 are cancelled. The pending claims are listed as an appendix.” App. Br. 3. Appellant’s Appendix to the Appeal Brief does not contain claims 83-89, nor have we found any indication that claims 83-89 were ever pending. Accordingly, we understand Appellant’s statement to be a typographical error and, as indicated on Appellant’s Notice of Appeal, that claims 83-89 are not at issue in this appeal. Appeal 2011-011083 Application 10/165,855 3 identify a projected health outcome corresponding to the first individual patient based upon a preference of the first individual patient and on a goal of the first individual patient; access, using the computer system, the database to retrieve information regarding health status parameters from a population having similar demographics to the first individual patient to provide a library of projected health outcomes for a plurality of treatments for the disease state of the first individual patient; and at least partly based on the first individual patient’s goal and preference, use the computer system to assist the patient and/or provider in selecting preferred outcomes from the library of projected health outcomes. The Examiner relies upon the following evidence: Dormond US 4,839,822 Jun. 13, 1989 Maggioncalda US 6,012,044 Jan. 4, 2000 Claims 63-82 stand rejected under 35 U.S.C. § 102(b) as being anticipated by Maggioncalda. Claims 63-82 stand rejected under 35 U.S.C. § 103(a) as being unpatentable over Dormond. FINDINGS OF FACT We find that the findings of fact which appear in the Analysis below are supported by at least a preponderance of the evidence. Ethicon, Inc. v. Quigg, 849 F.2d 1422, 1427 (Fed. Cir. 1988) (explaining the general evidentiary standard for proceedings before the Office). Appeal 2011-011083 Application 10/165,855 4 ANALYSIS Anticipation based on Maggioncalda Claims 63-82 Independent claim 63 is directed to a program stored in computer readable memory. The Examiner maintains that claim 63 recites instructions that are “not functionally related from the medium,” and therefore does not distinguish the claim over the cited prior art. See Ans. 4. The Examiner then relies on Maggioncalda, which discloses a user interface for a financial advisory system, as an anticipatory reference on the grounds that it “discloses a medium storing instructions for use by a processor of a computer.” Id. Contrary to the Examiner’s determination, we agree with Appellant that there is a functional interrelationship among the data referred to in claim 63 and the computing processes performed when utilizing that data. For example, claim 63 requires identifying a patient’s projected health outcome “based upon a preference of the first individual patient and on a goal of the first individual patient,” and then using the computer system to assist the patient and/or provider in selecting preferred outcomes “at least partly based on the first individual patient’s goal and preference.” Thus, data concerning a patient’s preference and goal is functionally related to selecting preferred outcomes, and therefore provides a limitation of the claim that is not disclosed by Maggioncalda and that cannot be disregarded as superfluous. Accordingly, we conclude that Appellant has overcome the Examiner’s rejection of claims 63-82 under 35 U.S.C. § 102(b) as being anticipated by Maggioncalda. Appeal 2011-011083 Application 10/165,855 5 Obviousness based on Dormond Claims 63-82 The Examiner maintains that Dormond (col. 7, ll. 5-25) discloses “identify[ing] a projected health outcome corresponding to the first individual patient based upon a preference of the first individual patient and on a goal of the first individual patient.” Ans. 5. The Examiner further explains that: Attention is directed to Dormond, where, a projected health outcome (ability to tolerate surgery, to heal properly, etc) is identified (col 7 ln 5-15) which corresponds to a patient’s preference and goal (“goals” at col 7 ln 65) also col 8 ln 1-15 where the user chooses a treatment based, inter alia, on statistical analysis of likely complications of each treatment depending on patient characteristics. Ans. 10. The Examiner has not shown how portions of the references cited disclose the claimed feature. Dormond (col. 7, ll. 5-25) discusses obtaining information from a patient about treatment concerns. Dormond (col. 7, l. 63-66) states that “[w]hen the inference engine has gathered all the necessary information, it completes its tasks by achieving certain ‘goals’, and then returns temporary control to the application program.” Dormond (col. 8, ll. 1-15) discusses treatments suggested by the inference engine. While the Examiner has shown that Dormond uses the word “goals,” that is not enough where the claim recites “a goal of the first individual patient,” and Dormond uses “goals” in reference to tasks completed by an inference engine. Accordingly, we conclude that Appellant has overcome the Examiner’s rejection of claims 63-82 under 35 U.S.C. § 103(a) as being unpatentable over Dormond. Appeal 2011-011083 Application 10/165,855 6 NEW GROUND OF REJECTION UNDER 37 C.F.R. § 41.50(b) Pursuant to our authority under 37 C.F.R. § 41.50(b), we enter a new ground of rejection under 35 U.S.C. § 101 for claims 63-82. The only independent claim, claim 63, recites “[a] program stored in computer readable memory.” Claims 63-82 are rejected under 35 U.S.C. § 101 as being directed to non-statutory subject matter (e.g., an intangible and/or transitory computer readable medium). Claims 63-82 are drawn to non-statutory subject matter because the broadest reasonable interpretation, in light of the Specification (Spec. 7, ll. 20-26), is that the program stored in computer readable memory could be embodied as transmission media that are transitory and/or intangible. See Subject Matter Eligibility of Computer Readable Media, 1351 Off. Gaz. Pat. Office 212 (Feb. 23, 2010). When the broadest reasonable interpretation of a claim covers a signal per se, the claim must be rejected under 35 U.S.C. § 101 as covering non-statutory subject matter. See In re Nuijten, 500 F.3d 1346, 1356-57 (Fed. Cir. 2007) (transitory embodiments are not directed to statutory subject matter); see also Ex parte Mewherter, Appeal No. 2012- 007692 (PTAB May 08, 2013) (precedential) (holding a claim must be rejected if it covers transitory media). In view of the foregoing, claims 63- 82 encompass non-statutory subject matter, and are therefore ineligible under § 101. DECISION We REVERSE the decision of the Examiner to reject claims 63-82 under 35 U.S.C. § 102(b) as being anticipated by Maggioncalda and under 35 U.S.C. § 103(a) as being unpatentable over Dormond. Appeal 2011-011083 Application 10/165,855 7 We have entered a NEW GROUND OF REJECTION of claims 63-82 pursuant to 37 C.F.R. § 41.50(b). 37 C.F.R. § 41.50(b) provides “[a] new ground of rejection pursuant to this paragraph shall not be considered final for judicial review.” 37 C.F.R. § 41.50(b) also provides that the Appellant, WITHIN TWO MONTHS FROM THE DATE OF THE DECISION, must exercise one of the following two options with respect to the new ground of rejection to avoid termination of the appeal as to the rejected claims: (1) Reopen prosecution. Submit an appropriate amendment of the claims so rejected or new evidence relating to the claims so rejected, or both, and have the matter reconsidered by the examiner, in which event the proceeding will be remanded to the Examiner. (2) Request rehearing. Request that the proceeding be reheard under 37 C.F.R. § 41.52 by the Board upon the same record. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). REVERSED; 37 C.F.R. § 41.50(b) mls Copy with citationCopy as parenthetical citation